A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer

PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

July 24, 2018

Primary Completion Date

December 27, 2022

Study Completion Date

December 27, 2022

Conditions
Reflux EsophagitisGastric UlcerDuodenal Ulcer
Interventions
DRUG

D961H capsule 10mg

All Groups can select either capsule or sachet during the study.

DRUG

D961H sachet 10mg

All Groups can select either capsule or sachet during the study.

Trial Locations (17)

113-8431

Research Site, Bunkyō City

113-8519

Research Site, Bunkyō City

417-8567

Research Site, Fuji-shi

594-1101

Research Site, Izumi-shi

890-8520

Research Site, Kagoshima

920-8641

Research Site, Kanazawa

602-8566

Research Site, Kyoto

371-8511

Research Site, Maebashi

390-8621

Research Site, Matsumoto-shi

701-1192

Research Site, Okayama

339-8551

Research Site, Saitama-shi

593-8304

Research Site, Sakaishi

157-8535

Research Site, Setagaya-ku

160-0023

Research Site, Shinjuku-ku

569-8686

Research Site, Takatsuki-shi

230-8765

Research Site, Yokohama

232 8555

Research Site, Yokohama

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY